|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation, amortization, and accretion, net | |||||
| Amortization of right-of-use assets | |||||
| Amortization of intangible assets | |||||
| Deferred income tax benefit | |||||
| Loss on sale of other real estate owned | |||||
| Loss on valuation of other real estate owned | |||||
| Provision for (recovery of) loan losses | |||||
| Loss on loans held for sale | |||||
| Gain on retirement of subordinated debt | |||||
| Loss on New Market Tax Credit investment operations | |||||
| Gain on disposal of premises and equipment | |||||
| Realized loss on securities called or matured | |||||
| Stock based compensation expense | |||||
| Income from bank owned life insurance | |||||
| Subordinated debt amortization expense | |||||
| Impairment of Intangible Assets, Finite-Lived | |||||
| Change in: | |||||
| Accrued interest receivable and other receivables | |||||
| Other assets | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Payments, available-for-sale securities | |||||
| Maturities, sales, called, refunded | |||||
| Purchases, available-for-sale securities | |||||
| Purchases | |||||
| Maturities, called, refunded | |||||
| Purchases of equity securities | |||||
| Purchases of restricted investment in bank stock | |||||
| Redemption of restricted investment in bank stock | |||||
| Net increase in loan portfolio | |||||
| Proceeds from sale of other real estate owned | |||||
| Proceeds from sale of loans | |||||
| Proceeds from sale of premises and equipment | |||||
| Purchase of premises and equipment, including property held for sale | |||||
| Computer software developed | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Net increase (decrease) in non-interest-bearing deposits | |||||
| Net increase (decrease) in interest-bearing demand, savings, NOW, money market and time deposits | |||||
| Net decrease in Federal Home Loan Bank advances | |||||
| Net increase (decrease) in federal funds purchased | |||||
| Net increase in subordinated debt | |||||
| Net decrease in subordinated debt | |||||
| Repurchase of common stock | |||||
| Cash dividends paid on preferred stock | |||||
| Cash dividends paid on common stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Increase (Decrease) in Cash and Cash Equivalents, net | |||||
| Cash and Cash Equivalents, beginning of period | |||||
| Cash and Cash Equivalents, end of period | |||||
| Supplementary Disclosure of Cash Flow Information | |||||
| Cash paid during the period for interest | |||||
| Cash paid during the period for income taxes, see Note 11 | |||||
| Supplemental Noncash Disclosures | |||||
| Transfers from loans to other real estate owned | |||||
| Net unrealized gain (loss) on securities available-for-sale | |||||
Loading...